Coordinating partners
This ESMO study was conducted under the auspices of the ESMO Global Policy Committee in collaboration with the:
- World Health Organization (WHO)
- European Society of Oncology Pharmacy (ESOP) - liaising with the International Society of Oncology Pharmacy Practitioners (ISOPP)
- Kings College London Institute of Cancer Policy
- Union for International Cancer Control (UICC)
Collaborating partners
- American Society of Clinical Oncology (ASCO)
- Chinese Society of Clinical Oncology (CSCO)
- Indian Society for Medical & Pediatric Oncology (ISMPO)
- Japanese Society of Medical Oncology (JSMO)
- Korean Society of Medical Oncology (KSMO)
- Myanmar Oncology Society (MOS)
- Medical Oncology Group of Australia Incorporated (MOGA)
- Medical Oncology Society of Peru (SPOM - Sociedad Peruana de Oncologia Médica)
- Middle East Cancer Consortium (MECC)